Substituted nucleosides, nucleotides and analogs thereof
Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.
1. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt of the foregoing.
2. A compound of the structure
or a pharmaceutically acceptable salt thereof.
3. A compound of the structure
or a pharmaceutically acceptable salt thereof.
4. A compound of the structure
or a pharmaceutically acceptable salt thereof.
5. A compound of the structure
or a pharmaceutically acceptable salt thereof.
6. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt of the foregoing.
7. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt of the foregoing.
8. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt of the foregoing.
9. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt of the foregoing.